NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT02427893 2016-11-15Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant MelanomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 3 Withdrawn